[FURL=https://www.industryarc.com/Research/Primary-Care-POC-Diagnostics-Market-Research-508528?utm_source=Briefingwire&utm_medium=Pressrelease&utm_campaign=PaidPressrelease]Primary Care POC Diagnostics Market[/FURL] size is estimated to reach $8.9 billion by 2026, growing at a CAGR of 3.5% during the forecast period 2021-2026. Point-of-Care (POC) Diagnostics allows physicians to accurately achieve real-time and quality diagnostic results within minutes rather than hours. POC diagnostics at primary care is essential for the rapid detection of analytes to the patient that facilitates better disease monitoring and management. These diagnostics ensure the patients receive the most efficient care and enable staff to make rapid treatment decisions. Rise in the adoption of self-glucose testing devices in developed nations to control glycemic levels regularly, growing demand for lateral flow assays owing to its low cost and user-friendliness, and increasing demand for coagulation testing at physician’s office are the factors that are set to drive the growth of the Primary Care POC Diagnostics Market for the period 2021-2026.Key Takeaways
Geographically, North America Primary Care POC Diagnostics Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing adoption of self-glucose testing devices in developed nations to control glycemic levels regularly.
The growing demand for coagulation testing at the physician’s office is driving the Physician Office segment. However, the stringent barriers faced by the key players owing to multi-layered regulations set by the Food and Drug Administration (FDA) is one of the major factors that is said to reduce the growth of the Primary Care POC Diagnostics Market.
Request for Sample of the Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=508528[/FURL]
Primary Care POC Diagnostics Market Segment Analysis-By Geography
North America held the largest share with 33% of the overall market in 2020. The growth in this segment is owing to the factors such as the growing adoption of self-glucose testing devices in developed nations to control glycemic levels regularly and the rise in the demand for POC technologies from the pharmacy and retail clinics. The increasing demand for coagulation testing at the physician’s office is driving the growth of the Primary Care POC Diagnostics Market.
Primary Care POC Diagnostics Market Drivers
Increase in the Demand for Lateral Flow Assays
Rise in the Adoption of Glucose Testing in Primary Care POC Diagnostics
Primary Care POC Diagnostics Market top 10 companies are Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Siemens Healthcare, BioMerieux, Quidel Corporation, BD Biosciences, Thermo Fisher Scientific, Agilent Technologies, and Qiagen among others.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.